# Tolerance and Pharmacokinetics Study of MNTX Tablets

> **NCT01366339** · PHASE1 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 37 (actual)

## Conditions studied

- Normal Healthy Volunteers

## Interventions

- **DRUG:** Oral methylnaltrexone
- **DRUG:** Oral placebo

## Key facts

- **NCT ID:** NCT01366339
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366339, "Tolerance and Pharmacokinetics Study of MNTX Tablets". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01366339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*